BioCentury
ARTICLE | Financial News

BioLineRx completes follow-on

March 31, 2017 7:33 PM UTC

Cancer and immunology company BioLineRx Ltd. (Tel Aviv:BLRX; NASDAQ:BLRX) raised $25 million through the sale of 29.4 million ADSs at $0.85 in a follow-on underwritten by JMP Securities, H.C. Wainwri...

BCIQ Company Profiles

BioLineRx Ltd.